附录99.1
Talkspace宣布2024年第三季度业绩
2024年第三季度总营业收入同比增长23%,增长幅度主要由45%推动
Payor营业收入的年度同比增长
净利润提高至190万美元。
由每股$440万的净亏损逐年增加
2024年第三季度调整后的EBITDA1 为240万美元
纽约,纽约 - 2024年10月29日 – Talkspace, Inc。 ("Talkspace"或"公司")(纳斯达克:TALK),今天公布了2024年第三季度财务业绩。
|
|
三个月 |
|
九个月 |
||||
|
|
|
||||||
2024年9月30日 (未经查核) |
|
结果 |
|
与前一年相比的变异% |
|
结果 |
|
与前一年相比的变异% |
(除非另有说明,数字单位为千) |
|
|
|
|
|
|
|
|
期末合格受益人数 (以百万为单位) |
|
158.1 |
|
40% |
|
158.1 |
|
40% |
完成付款会员次数 |
|
316.4 |
|
38% |
|
899.2 |
|
50% |
期末消费者活跃会员数 |
|
8.6 |
|
(35)% |
|
8.6 |
|
(35)% |
|
|
|
|
|
|
|
|
|
营业总收入 |
|
$47,399 |
|
23% |
|
$138,873 |
|
29% |
毛利润 |
|
$21,621 |
|
15% |
|
$64,303 |
|
20% |
归属于nCino, Inc.的净亏损 |
|
45.6% |
|
|
|
46.3% |
|
|
营业费用 |
|
$21,522 |
|
(10)% |
|
$69,369 |
|
(6)% |
净利润(损失) |
|
$1,874 |
|
* |
|
$(66) |
|
100% |
调整后的税前利润减除折旧及摊销后的费用 (1) |
|
$2,350 |
|
* |
|
$4,303 |
|
* |
期末现金及现金等价物 |
|
$118,994 |
|
— |
|
$118,994 |
|
— |
* 百分比无意义。
Talkspace交出了稳固的第三季度财务业绩,营业收入增长23%,连续第三个获得调整后的EBITDA盈利的季度。我们在加强与重要付款伙伴的关系方面取得了重大进展,他们认为我们是最领先的全面、纯粹的行为健康提供者,真正认识到我们对临床卓越的差异化关注的重要性。
cohen博士表示:“心理健康危机仍然是一个关键问题,Talkspace通过我们高素质、有不同临床许可的供应商和创新平台,处于应对这种需求的最前沿。我特别为我们扩张至目前为止服务超过15800万被保险人一事感到自豪,其中包括为老年人、青少年和军工成员提供更多资源,这些人群具有独特且迫切的行为健康需求。我们创新的方法和战略性扩张使我们成为美国最大的行为远程健康网络,使我们能够满足对可及、高质量行为健康服务日益增长的需求。”
1
2024年第三季关键业绩指标
财务指导
Talkspace仍预计2024财政年度的营业收入在18500万到19500万的区间内,增长23-30%,且调整后的EBITDA在400万到800万的区间内。
2
会议看涨、演讲投影片和网路转播详情
2024年第三季度业绩发布会将于2024年10月29日星期二上午8:30举行。业绩发布会将透过投资者.talkspace.com提供听觉网路转播,美国参与者可拨打(888) 596-4144,国际参与者可拨打+1(646) 968-2525,并提供参与者代码2125813。通话完成后将立即提供重播,并持续约90天。
关于Talkspace
Talkspace(纳斯达克: TALK)是一家领先的虚拟行为健康照护提供者,致力于帮助人们通过获得高质量的心理照护来过上更健康、更快乐的生活。在Talkspace,我们相信心理照护对于整体健康至关重要,应该向每个人提供。
Talkspace开创了与注册治疗师能够进行文字交流的先河,现在提供全面的心理健康服务,包括个人、青少年和夫妻治疗,以及精神治疗和药物管理(18+)。通过Talkspace的核心治疗服务,会员可在几天内与数千名注册治疗师中的一名配对,进行现场视频、音频或聊天会话,以及无限制的非同步文字消息交流。
所有板块Talkspace提供的所有护理都是通过易于使用、完全加密的网络和移动平台进行交付,符合HIPAA、联邦和州政府的要求。超过15800万名美国人通过他们的医疗保险计划、员工援助计划、我们与领先医疗公司的合作伙伴关系,或者作为他们的雇主、学校或政府机构的免费福利获得了Talkspace的服务。
欲了解更多资讯,请浏览www.talkspace.com。
对于投资者:
ICR Westwicke
TalkspaceIR@westwicke.com
媒体:
约翰·金
斯克德克
(310) 997-5963
jkim@skdknick.com
3
前瞻性陈述
本新闻稿包含根据1995年修订版《私人证券诉讼改革法案》的某些前瞻性陈述。所有不涉及历史事实的陈述应被视为前瞻性,包括有关我们财务状况、预期的财务表现、实现盈利能力、业务策略和计划、市场机会和扩张,以及我们管理层对未来运营目标的陈述。这些前瞻性陈述通常通过“预计”、“相信”、“思量”、“继续”、“可能”、“估计”、“预期”、“预测”、“未来”、“打算”、“可能”、“机会”、“计划”、“可能”、“潜在”、“预测”、“计划”、“策略”、“努力”、“目标”、“将”或“将会”等词语或表达来识别。缺乏这些词语并不意味著陈述不是前瞻性。前瞻性陈述是预测、预测和基于当前期望和假设的其他未来事件陈述,因此受风险和不确定性的影响。许多重要因素可能导致实际未来事件与本新闻稿中的前瞻性陈述有很大不同,其中包括但不限于:(i)我们的业务和我们运营的市场快速演变;(ii)我们行业中的快速技术变革;(iii)我们确保客户合同续订的能力;(iv)我们维护和扩大我们的治疗师、精神科医生和其他提供者网络的能力;(v)企业赞助的医疗保健普及率下降或新技术的出现可能对我们的DTE业务产生不利影响;(vi)如果我们或我们的供应商的安全措断失败或被侵犯;(vii)医疗保健行业法律、法规或趋势的变化以及我们在受严格监管的医疗保健行业营运的能力;和(viii)以及其他因素、风险和不确定性,详见我们最近于2024年3月13日向证券交易委员会(“SEC”)提交的最新年度报告Form 10-k中标题为“风险因素”的描述、随后的季报Form 10-Q和我们不定期向SEC提交的其他文件。这些文件确定并解决了可能导致实际事件和结果与前瞻性陈述不符的其他重要风险和不确定性。前瞻性陈述仅于其发布之日起有效。读者应谨慎对待前瞻性陈述,我们不承担任何责任并无意更新或修订这些前瞻性陈述,除非根据适用法律有此要求。我们不保证实现我们的期望。
4
Talkspace, Inc.
Condensed Consolidated Income Statements
|
|
Three Months Ended |
|
|
|
Nine Months Ended |
|
|
||||
|
|
2024 |
|
2023 |
|
% Change |
|
2024 |
|
2023 |
|
% Change |
(in thousands, except percentages, share and per share data) |
|
Unaudited |
|
Unaudited |
|
|
|
Unaudited |
|
Unaudited |
|
|
Revenue: |
|
|
|
|
|
|
|
|
|
|
|
|
Payor revenue |
|
$32,039 |
|
$22,112 |
|
44.9 |
|
$90,492 |
|
$55,462 |
|
63.2 |
DTE revenue |
|
9,370 |
|
8,002 |
|
17.1 |
|
28,911 |
|
24,717 |
|
17.0 |
Consumer revenue |
|
5,990 |
|
8,532 |
|
(29.8) |
|
19,470 |
|
27,448 |
|
(29.1) |
Total revenue |
|
47,399 |
|
38,646 |
|
22.6 |
|
138,873 |
|
107,627 |
|
29.0 |
Cost of revenues |
|
25,778 |
|
19,797 |
|
30.2 |
|
74,570 |
|
54,218 |
|
37.5 |
Gross profit |
|
21,621 |
|
18,849 |
|
14.7 |
|
64,303 |
|
53,409 |
|
20.4 |
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
2,352 |
|
4,180 |
|
(43.7) |
|
8,254 |
|
13,704 |
|
(39.8) |
Clinical operations, net |
|
1,677 |
|
1,405 |
|
19.4 |
|
4,802 |
|
4,681 |
|
2.6 |
Sales and marketing |
|
12,337 |
|
13,184 |
|
(6.4) |
|
38,615 |
|
39,698 |
|
(2.7) |
General and administrative |
|
5,156 |
|
5,259 |
|
(2.0) |
|
17,698 |
|
15,952 |
|
10.9 |
Total operating expenses |
|
21,522 |
|
24,028 |
|
(10.4) |
|
69,369 |
|
74,035 |
|
(6.3) |
Income (loss) from operations |
|
99 |
|
(5,179) |
|
* |
|
(5,066) |
|
(20,626) |
|
75.4 |
Financial (income), net |
|
(1,701) |
|
(779) |
|
118.4 |
|
(5,123) |
|
(2,915) |
|
75.7 |
Income (loss) before taxes on income |
|
1,800 |
|
(4,400) |
|
* |
|
57 |
|
(17,711) |
|
* |
Taxes on income |
|
(74) |
|
14 |
|
* |
|
123 |
|
165 |
|
(25.5) |
Net income (loss) |
|
$1,874 |
|
$(4,414) |
|
* |
|
$(66) |
|
$(17,876) |
|
99.6 |
Net income (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$0.01 |
|
$(0.03) |
|
* |
|
$(0.00) |
|
$(0.11) |
|
99.6 |
Diluted |
|
$0.01 |
|
$(0.03) |
|
* |
|
$(0.00) |
|
$(0.11) |
|
99.6 |
Weighted average shares used to compute net income (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
168,426,349 |
|
166,570,673 |
|
|
|
168,805,882 |
|
164,215,802 |
|
|
Diluted |
|
176,227,040 |
|
166,570,673 |
|
|
|
168,805,882 |
|
164,215,802 |
|
|
* Percentage not meaningful.
5
Talkspace, Inc.
Condensed Consolidated Balance Sheets
|
|
|
|
|||||
|
|
September 30, 2024 |
|
|
December 31, 2023 |
|
||
(in thousands) |
|
Unaudited |
|
|
|
|
||
ASSETS |
|
|
|
|
|
|
||
CURRENT ASSETS: |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
118,994 |
|
|
$ |
123,908 |
|
Accounts receivable, net |
|
|
9,602 |
|
|
|
10,174 |
|
Other current assets |
|
|
2,922 |
|
|
|
5,718 |
|
Total current assets |
|
|
131,518 |
|
|
|
139,800 |
|
Other long-term assets |
|
|
6,713 |
|
|
|
2,421 |
|
Total assets |
|
$ |
138,231 |
|
|
$ |
142,221 |
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
|
|
||
CURRENT LIABILITIES: |
|
|
|
|
|
|
||
Accounts payable |
|
$ |
8,299 |
|
|
$ |
6,111 |
|
Deferred revenues |
|
|
3,507 |
|
|
|
3,069 |
|
Accrued expenses and other current liabilities |
|
|
7,247 |
|
|
|
12,468 |
|
Total current liabilities |
|
|
19,053 |
|
|
|
21,648 |
|
Warrant liabilities |
|
|
1,048 |
|
|
|
1,842 |
|
Other liabilities |
|
|
542 |
|
|
|
85 |
|
Total liabilities |
|
|
20,643 |
|
|
|
23,575 |
|
STOCKHOLDERS’ EQUITY: |
|
|
|
|
|
|
||
Common stock |
|
|
17 |
|
|
|
16 |
|
Additional paid-in capital |
|
|
388,021 |
|
|
|
389,014 |
|
Accumulated deficit |
|
|
(270,450 |
) |
|
|
(270,384 |
) |
Total stockholders’ equity |
|
|
117,588 |
|
|
|
118,646 |
|
Total liabilities and stockholders’ equity |
|
$ |
138,231 |
|
|
$ |
142,221 |
|
6
Talkspace, Inc.
Condensed Consolidated Statements of Cash Flows
|
|
Nine Months Ended |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
(in thousands) |
|
Unaudited |
|
|
Unaudited |
|
||
Cash flows from operating activities: |
|
|
|
|
|
|
||
Net loss |
|
$ |
(66 |
) |
|
$ |
(17,876 |
) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
||
Depreciation and amortization |
|
|
652 |
|
|
|
913 |
|
Stock-based compensation |
|
|
7,290 |
|
|
|
6,401 |
|
Remeasurement of warrant liabilities |
|
|
(794 |
) |
|
|
647 |
|
Decrease in accounts receivable |
|
|
572 |
|
|
|
1,668 |
|
Decrease (increase) in other current assets |
|
|
2,796 |
|
|
|
(41 |
) |
Increase in accounts payable |
|
|
2,188 |
|
|
|
51 |
|
Increase (decrease) in deferred revenues |
|
|
438 |
|
|
|
(733 |
) |
Decrease in accrued expenses and other current liabilities |
|
|
(5,220 |
) |
|
|
(5,785 |
) |
Other |
|
|
(233 |
) |
|
|
(108 |
) |
Net cash provided by (used in) operating activities |
|
|
7,623 |
|
|
|
(14,863 |
) |
Cash flows from investing activities: |
|
|
|
|
|
|
||
Capitalized internal-use software costs |
|
|
(3,768 |
) |
|
|
— |
|
Other |
|
|
(69 |
) |
|
|
(10 |
) |
Net cash used in investing activities |
|
|
(3,837 |
) |
|
|
(10 |
) |
Cash flows from financing activities: |
|
|
|
|
|
|
||
Proceeds from exercise of stock options |
|
|
1,616 |
|
|
|
2,059 |
|
Payments for employee taxes withheld related to vested stock-based awards |
|
|
(2,312 |
) |
|
|
(399 |
) |
Repurchase and cancellation of common stock |
|
|
(8,004 |
) |
|
|
— |
|
Net cash (used in) provided by financing activities |
|
|
(8,700 |
) |
|
|
1,660 |
|
Net decrease in cash and cash equivalents |
|
|
(4,914 |
) |
|
|
(13,213 |
) |
Cash and cash equivalents at the beginning of the period |
|
|
123,908 |
|
|
|
138,545 |
|
Cash and cash equivalents at the end of the period |
|
$ |
118,994 |
|
|
$ |
125,332 |
|
7
Non-GAAP Financial Measures
In addition to our financial results determined in accordance with GAAP, we believe adjusted EBITDA, a non-GAAP measure, is useful in evaluating our operating performance, and our management uses it as a key performance measure to assess our operating performance. Because adjusted EBITDA facilitates internal comparisons of our historical operating performance on a more consistent basis, we use this measure for business planning purposes and in evaluating acquisition opportunities. We also use adjusted EBITDA to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that this non-GAAP financial measure, when taken together with the corresponding GAAP financial measures, provides meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our business, results of operations or outlook. We believe that the use of adjusted EBITDA is helpful to our investors as it is a metric used by management in assessing the health of our business and our operating performance. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP.
Some of the limitations of adjusted EBITDA include (i) adjusted EBITDA does not necessarily reflect capital commitments to be paid in the future and (ii) although depreciation and amortization are non-cash charges, the underlying assets may need to be replaced and adjusted EBITDA does not reflect these requirements. In evaluating adjusted EBITDA, you should be aware that in the future we will incur expenses similar to the adjustments described herein. Our presentation of adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these expenses or any unusual or non-recurring items. Our adjusted EBITDA may not be comparable to similarly titled measures of other companies because they may not calculate adjusted EBITDA in the same manner as we calculate the measure, limiting its usefulness as a comparative measure. Adjusted EBITDA should not be considered as an alternative to income (loss) before income taxes, net income (loss), income (loss) per share, or any other performance measures derived in accordance with U.S. GAAP. When evaluating our performance, you should consider adjusted EBITDA alongside other financial performance measures, including our net income (loss) and other GAAP results.
A reconciliation is provided below for adjusted EBITDA to net income (loss), the most directly comparable financial measure stated in accordance with GAAP. Investors are encouraged to review our financial statements prepared in accordance with GAAP and the reconciliation of our non-GAAP financial measure to its most directly comparable GAAP financial measure, and not to rely on any single financial measure to evaluate our business. We do not provide a forward-looking reconciliation of adjusted EBITDA guidance as the amount and significance of the reconciling items required to develop meaningful comparable GAAP financial measures cannot be estimated at this time without unreasonable efforts. These reconciling items could be meaningful.
8
Adjusted EBITDA
We calculate adjusted EBITDA as net income (loss) adjusted to exclude (i) depreciation and amortization, (ii) interest and other expenses (income), net, (iii) tax benefit and expense, (iv) stock-based compensation expense, and (v) certain non-recurring expenses, where applicable.
Talkspace, Inc.
Reconciliation of Non-GAAP Results to GAAP Results
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
(in thousands) |
|
Unaudited |
|
|
Unaudited |
|
|
Unaudited |
|
|
Unaudited |
|
||||
Net income (loss) |
|
$ |
1,874 |
|
|
$ |
(4,414 |
) |
|
$ |
(66 |
) |
|
$ |
(17,876 |
) |
Add: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Depreciation and amortization |
|
|
231 |
|
|
|
305 |
|
|
|
652 |
|
|
|
913 |
|
Financial (income), net (1) |
|
|
(1,701 |
) |
|
|
(779 |
) |
|
|
(5,123 |
) |
|
|
(2,915 |
) |
Taxes on income |
|
|
(74 |
) |
|
|
14 |
|
|
|
123 |
|
|
|
165 |
|
Stock-based compensation |
|
|
1,931 |
|
|
|
1,969 |
|
|
|
7,290 |
|
|
|
6,401 |
|
Non-recurring expenses (2) |
|
|
89 |
|
|
|
105 |
|
|
|
1,427 |
|
|
|
89 |
|
Adjusted EBITDA |
|
$ |
2,350 |
|
|
$ |
(2,800 |
) |
|
$ |
4,303 |
|
|
$ |
(13,223 |
) |
9